| Clinical implications of the ethics of informed consent for first-trimester risk assessment for trisomy 21. | |
| | |
MedLine Citation:
|
PMID: 16104682 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: We identify the clinical implications of the ethics of informed consent for risk assessment for trisomy 21. FINDING: Based on the ethics of informed consent, we find that routinely offering first-trimester risk assessment in centers qualified to provide it is ethically obligatory, and routinely withholding the results of first-trimester risk assessment is ethically unjustified. CONCLUSION: The ethics of informed consent is an essential dimension of first-trimester risk assessment for trisomy 21. |
| | |
Authors:
|
Frank A Chervenak; Laurence B McCullough; Stephen T Chasen |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Seminars in perinatology Volume: 29 ISSN: 0146-0005 ISO Abbreviation: Semin. Perinatol. Publication Date: 2005 Aug |
Date Detail:
|
Created Date: 2005-08-17 Completed Date: 2005-12-22 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7801132 Medline TA: Semin Perinatol Country: United States |
Other Details:
|
Languages: eng Pagination: 277-9 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Weill Medical College of Cornell University, New York, NY 10021, USA. fac2001@med.cornell.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Down Syndrome
/
diagnosis* Ethics, Medical* Female Fetal Diseases / diagnosis* Humans Informed Consent / ethics*, psychology Nuchal Translucency Measurement / ethics Pregnancy Pregnancy Trimester, First Prenatal Diagnosis / ethics* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Nuchal translucency-based Down syndrome screening: barriers to implementation.
Next Document: Tailoring porphyrins and chlorins for self-assembly in biomimetic artificial antenna systems.